Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism

Department of Haematology, Beaumont Hospital, Dublin, Ireland; RCSI University of Medicine and Health Sciences
Department of Haematology, Beaumont Hospital, Dublin, Ireland; RCSI University of Medicine and Health Sciences
Department of Haematology, Beaumont Hospital, Dublin, Ireland; RCSI University of Medicine and Health Sciences
Department of Haematology, Beaumont Hospital, Dublin, Ireland; RCSI University of Medicine and Health Sciences
Haematologica Early view Mar 6, 2025 https://doi.org/10.3324/haematol.2025.287442

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2025.287442
 
Published
2025-03-06
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
57
PDF Downloads
29

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online